Table IV.
Biological process: immunity and defense
| NCBI | Symbol | Gene name | FC | FDR |
|---|---|---|---|---|
| 3569 | IL-6 | Interleukin-6 | 16.1 | 0 |
| 7057 | THBS1 | Thrombospondin 1 | 3.83 | 0 |
| 4938 | OAS1 | 2′,5′-Oligoadenylate synthetase 1, 40/46 kDa | 2.71 | 0 |
| 10135 | PBEF1* | Pre-B-cell colony enhancing factor 1 | 2.67 | 0 |
| 4929 | NR4A2 | Nuclear receptor subfamily 4, group A, member 2 | 2.6 | 0 |
| 115908 | CTHRC1 | Collagen triple helix repeat containing 1 | 1.94 | 0 |
| 23643 | LY96 | Lymphocyte antigen 96 | 1.69 | 0 |
| 5359 | PLSCR1 | Phospholipid scramblase 1 | 1.57 | 0 |
| 3383 | ICAM1 | Intercellular adhesion molecule 1 | 6.5 | 2.94 |
| 10135 | PBEF1* | Pre-B-cell colony enhancing factor 1 | 3.52 | 2.94 |
| 5743 | PTGS2 | Prostaglandin-endoperoxide synthase 2 | 3.02 | 2.94 |
| 6347 | CCL2 | Chemokine (C–C motif) ligand 2 | 3.01 | 2.94 |
| 1520 | CTSS | Cathepsin S | 2.3 | 2.94 |
| 969 | CD69 | CD69 molecule | 2.25 | 2.94 |
| 6648 | SOD2 | Superoxide dismutase 2, mitochondrial | 2.08 | 2.94 |
| 3588 | IL-10RB | Interleukin 10 receptor, beta | 1.91 | 2.94 |
| 7852 | CXCR4 | Chemokine (C-X-C motif) receptor 4 | 1.89 | 2.94 |
| 9516 | LITAF | Lipopolysaccharide-induced TNF factor | 1.74 | 2.94 |
| 120892 | IRRK2 | Leucine-rich repeat kinase 2 | 1.7 | 2.94 |
| 7058 | THBS2 | Thrombospondin 2 | 1.62 | 2.94 |
| 8743 | TNFSF10 | Tumor necrosis factor (ligand) superfamily, member 10 | 1.62 | 2.94 |
| 4792 | NFKBIA | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 1.61 | 2.94 |
| 84168 | ANTXR1* | Anthrax toxin receptor 1 | 1.56 | 2.94 |
| 1604 | DAF | Decay accelerating factor for complement (Cromer blood group) | 1.56 | 2.94 |
| 199 | AIF1 | Allograft inflammatory factor 1 | 1.54 | 2.94 |
| 3428 | IFI16 | Interferon, gamma-inducible protein 16 | 1.51 | 2.94 |
| 1154 | CISH | Cytokine-inducible SH2-containing protein | 2.56 | 3.28 |
| 3164 | NR4A1 | Nuclear receptor subfamily 4, group A, member 1 | 2.36 | 3.28 |
| 8013 | NR4A3 | Nuclear receptor subfamily 4, group A, member 3 | 10.5 | 3.71 |
| 5329 | PLAUR | Plasminogen activator, urokinase receptor | 4.2 | 3.71 |
| 3659 | IRF1 | Interferon regulatory factor 1 | 4.07 | 3.71 |
| 2920 | CXCL2 | Chemokine (C-X-C motif) ligand 2 | 3.94 | 3.71 |
| 4616 | GADD45B | Growth arrest and DNA-damage-inducible, beta | 3.22 | 3.71 |
| 25801 | GCA | Grancalcin, EF-hand calcium binding protein | 1.92 | 3.71 |
| 4783 | NFIL3 | Nuclear factor, interleukin 3 regulated | 1.91 | 3.71 |
| 3119 | HLA-DQB1 | Major histocompatibility complex, class II, DQ beta 1 | 1.6 | 3.71 |
| 5889 | RAD51C | RAD51 homolog C (Saccharomyces cerevisiae) | 1.54 | 3.71 |
| 5966 | REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 2.46 | 3.83 |
| 29015 | PRG2; SLC43A3 | Solute carrier family 43, member 3 | 1.51 | 3.83 |
| 3563 | IL3RA | Interleukin 3 receptor, alpha (low affinity) | 2.43 | 4.31 |
| 7056 | THBD | Thrombomodulin | 1.97 | 4.31 |
| 3459 | IFNGR1 | Interferon gamma receptor 1 | 1.61 | 4.31 |
| 3437 | IFIT4 or IFIT3 | Interferon-induced protein with tetratricopeptide repeats 3 | 1.58 | 4.31 |
| 3553 | IL-1B | Interleukin 1, beta | 5.35 | 5.18 |
| 2919 | CXCL1 | Chemokine (C-X-C motif) ligand 1 | 2.71 | 5.18 |
| 4332 | MNDA | Myeloid cell nuclear differentiation antigen | 2.65 | 5.18 |
| 4688 | NCF2 | Neutrophil cytosolic factor 2 | 2.63 | 5.18 |
| 84168 | ANTXR1* | Anthrax toxin receptor 1 | 2.53 | 5.18 |
| 5996 | RGS1 | Regulator of G-protein signaling 1 | 2.5 | 5.18 |
| 7127 | TNFAIP2 | Tumor necrosis factor, alpha-induced protein 2 | 1.61 | 5.18 |
| 3460 | IFNGR2 | Interferon gamma receptor 2 (interferon gamma transducer 1) | 1.54 | 5.18 |
| 3117 | HLA-DQA1 | Major histocompatibility complex, class II, DQ alpha 1 | 1.52 | 5.18 |
Genes with an FC of 1.5 or above and FDR of 5.18 or less.
*PBEF and ANTRX1 had more than one probe.
NCBI, National Center for Biotechnology Information.